Has Philipp Taussky, MD received payments from drug or device companies?

Yes. Drug and device makers reported $223,757 in general payments to Philipp Taussky, MD across 263 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Philipp Taussky, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Philipp Taussky, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Philipp Taussky, MD

Neurological Surgery · Boston, MANPI 1982837084

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (45.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Medtronic at 47.4% of the total. Reporting peaked in 2022 at $54,093 and has fallen 79.9% since, to $10,879 in 2025. Among neurological surgery clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$223,757in general payments, 2019–2025

Across 263 payments — averaging $850.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$106K
Medical Device Business Services, Inc.$76K
Phenox Inc.$13K
Rapid Medical Ltd$12K
Stryker$7K
Depuy Synthes Products, Inc.$6K
plus $3K from 13 others

$255,209in research payments, 2019–2025

Across 54 payments — averaging $4726.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Stryker$172K
Medical Device Business Services, Inc.$49K
Medtronic$34K

What the payments were for

Consulting fees$101,97646%
Speaking & faculty fees$64,42729%
Travel & lodging$47,01821%
Food & beverage$10,3245%
Gifts$120%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	111	$106,103
Medical Device Business Services, Inc.	78	$76,086
Phenox Inc.	2	$13,403
Rapid Medical Ltd	4	$12,241
Stryker	14	$6,992
Depuy Synthes Products, Inc.	4	$5,545
Microvention, Inc.	9	$1,165
Johnson & Johnson	11	$673
Imperative Care, Inc	13	$330
Balt USA, LLC	2	$311
Biosense Webster, Inc.	4	$306
Viz.ai, Inc.	1	$126
Inspiremd Ltd	1	$106
Siemens Medical Solutions USA, Inc.	1	$95
Integra Lifesciences Corporation	3	$90
Philips North America LLC	1	$80
Route 92 Medical, Inc.	1	$55
Aesculap, Inc.	2	$39
Si-bone, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TRUFILL$55,091
Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device$54,091
Pipeline$50,983
CEREPAK UNIFORM$15,782
Embotrap$13,883
Avenir Coils$13,336
Covidien-Access$12,600
TIGERTRIEVER 17 REVASCULARIZATION DEVICE$12,241
COMANECI 17$12,241
EMBOTRAP II Revascularization Device$9,630
EMBOGUARD$7,800
Covidien-Liquid Embolics$6,000
TREVO$5,738
PULSERIDER$1,000
SURPASS EVOLVE$765
WEB Aneurysm Embolization System$599
STENT$322
Optima Coil System$311
WEB$268
BIOPATCH$232

How this compares

$223,757 in reported general payments places this provider in the 90th percentile of 183 neurological surgery providers in Massachusetts.

See all neurological surgery providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$92,967

Medicare patients

135

Services billed

265

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Boston

Simcha WellerBoston$905K
Aman PatelBoston$734K
Alireza AtriBoston$503K
Myron RolleBoston$290K
John ChiBoston$280K
Robert RichardsonBoston$190K
Brendon BootBoston$149K
Muhammad Abd-El-BarrBoston$140K
Brian NahedBoston$97K
Thomas NohBoston$69K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →